We are live on ! Find out more
SC

Solstein Capital Portfolio holdings

AUM $244M
1-Year Est. Return 29.05%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+29.05%
3 Year Est. Return
+83.62%
5 Year Est. Return
+122.39%
10 Year Est. Return
AUM
$189M
AUM Growth
+$35.6M
Cap. Flow
+$28.4M
Cap. Flow %
15.03%
Top 10 Hldgs %
45.49%
Holding
323
New
8
Increased
8
Reduced
23
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Consumer Discretionary 7.68%
3 Financials 5.82%
4 Communication Services 4.91%
5 Healthcare 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLM icon
226
Martin Marietta Materials
MLM
$34.3B
$14K 0.01%
26
DEO icon
227
Diageo
DEO
$47.3B
$13.9K 0.01%
99
-419
-81% -$54.4K
BRK.B icon
228
Berkshire Hathaway Class B
BRK.B
$1.07T
$13.8K 0.01%
30
STX icon
229
Seagate
STX
$185B
$13.7K 0.01%
125
CTVA icon
230
Corteva
CTVA
$58.6B
$13.6K 0.01%
231
TFC icon
231
Truist Financial
TFC
$63.7B
$13.3K 0.01%
311
NDSN icon
232
Nordson
NDSN
$16.6B
$12.9K 0.01%
49
ROL icon
233
Rollins
ROL
$18.8B
$12.4K 0.01%
246
EFX icon
234
Equifax
EFX
$20.8B
$12.3K 0.01%
42
PAYX icon
235
Paychex
PAYX
$41.1B
$12.2K 0.01%
91
MCHP icon
236
Microchip Technology
MCHP
$42.3B
$12.2K 0.01%
152
BIDU icon
237
Baidu
BIDU
$35.8B
$12K 0.01%
114
-24
-17% -$2.12K
LHX icon
238
L3Harris
LHX
$56.5B
$11.4K 0.01%
48
ACN icon
239
Accenture
ACN
$94.3B
$11K 0.01%
31
NUE icon
240
Nucor
NUE
$56.4B
$10.5K 0.01%
70
ANSS
241
DELISTED
Ansys
ANSS
$10.5K 0.01%
33
WST icon
242
West Pharmaceutical
WST
$23.3B
$10.2K 0.01%
34
NKE icon
243
Nike
NKE
$62.5B
$10.1K 0.01%
114
BRKR icon
244
Bruker
BRKR
$9.14B
$9.67K 0.01%
140
TEL icon
245
TE Connectivity
TEL
$60.2B
$9.66K 0.01%
64
PLTR icon
246
Palantir
PLTR
$315B
$9.3K ﹤0.01%
250
ILMN icon
247
Illumina
ILMN
$28.7B
$9.26K ﹤0.01%
71
PANW icon
248
Palo Alto Networks
PANW
$259B
$9.23K ﹤0.01%
54
MNST icon
249
Monster Beverage
MNST
$93.2B
$9.03K ﹤0.01%
173
DOV icon
250
Dover
DOV
$27.7B
$8.82K ﹤0.01%
46

Similar funds

Solstein Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Solstein Capital held 323 positions worth $189M, up 23% from $153M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Solstein Capital deployed $28.4M of net new capital in Q3 2024, opening 8 new positions and adding to 8 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 15,798 shares worth $9.11M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Novo Nordisk, an estimated $667K trimmed.

  • Solstein Capital's largest Q3 2024 buy was iShares Core S&P 500 ETF: 15,798 shares worth $9.11M.
  • Solstein Capital added most to iShares Core MSCI International Developed Markets ETF in Q3 2024, an estimated $9.16M increase.
  • Solstein Capital's biggest Q3 2024 reduction was Novo Nordisk, cutting an estimated $667K.
  • Solstein Capital fully exited ICL Group in Q3 2024, selling an estimated $56.5K.
  • Solstein Capital's ten largest holdings make up 45% of its $189M portfolio in Q3 2024.
  • Solstein Capital opened 8 new positions and closed 9 in Q3 2024.
  • Solstein Capital's portfolio value rose 23% quarter-over-quarter to $189M.

Based on Solstein Capital's 13F filing for Q3 2024, filed 29 Oct 2024.